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Hox genes are essential for the patterning of the axial
skeleton. Hox group 10 has been shown to specify
the lumbar domain by setting a rib-inhibiting pro-
gram in the presomitic mesoderm (PSM). We have
now produced mice with ribs in every vertebra by
ectopically expressing Hox group 6 in the PSM,
indicating that Hox genes are also able to specify
the thoracic domain. We show that the information
provided by Hox genes to specify rib-containing
and rib-less areas is first interpreted in the myotome
through the regional-specific control of Myf5 and
Myf6 expression. This information is then transmitted
to the sclerotome by a system that includes FGF and
PDGF signaling to produce vertebrae with or without
ribs at different axial levels. Our findings offer a new
perspective of how Hox genes produce global pat-
terns in the axial skeleton and support a redundant
nonmyogenic role of Myf5 and Myf6 in rib formation.
INTRODUCTION
Hox genes have been classically described to be involved in the
production of vertebrae with individual characteristics (Krumlauf
1994; Wellik 2007; Mallo et al., 2009). More recently, it was
discovered that Hox genes also play essential roles in defining
global vertebral domains (Wellik and Capecchi, 2003). In partic-
ular, it was shown that Hox group 10 is responsible for the layout
of the rib-less lumbar region by diverting it from a rib-containing
thoracic identity (Wellik and Capecchi, 2003; Carapuc¸o et al.,
2005). In addition, Hox group 11 was demonstrated to be
required for the formation of the sacrum (Wellik and Capecchi,
2003). However, it remains unclear whether or not Hox genes
are involved in the global specification of the thoracic and
cervical domains. Moreover, the mechanism by which Hox
genes control these processes is completely unknown.
Wellik and Capecchi, (2003) proposed that ribs are set out by
default and that the rib-less cervical domain would result fromDevethe rib-blocking activity of other Hox genes acting similarly to
Hox group 10 in the lumbar region. However, this hypothesis is
difficult to reconcile with published expression patterns for Hox
genes (Burke et al., 1995), which instead suggest an alternative
hypothesis. In particular, the anterior limit of expression of
members of the Hox group 6 correlates with the cervical-to-
thoracic transition in a variety of vertebrates bearing a different
number of cervical vertebrae (Burke et al., 1995), indicating
that this Hox group might have a role in promoting rib formation.
Here we present evidence supporting this hypothesis, showing
that Hox control of rib formation is mediated by regulation of
Myf5 and Myf6 expression in the hypaxial myotome through
interaction with a relevant enhancer. Moreover, our transgenic
analyses indicate that myotomal Myf5/Myf6 activation triggers
a nonautonomous effect mediated by PDGF and FGF signaling,
promoting rib formation in the adjacent sclerotome. Our data
support a redundant nonmyogenic role of Myf5 and Myf6 in the
processes leading to rib formation.RESULTS
Overexpression of Hox Group 6 Induces Ectopic
Rib Formation
In order to test whether Hox group 6 activity could induce rib
formation, we employed a transgenic approach to overexpress
Hoxb6 either in the presomitic mesoderm (PSM) or in the somites
of mouse embryos. While somite-exclusive expression gave mild
phenotypes (see Figures S1A and S1B available online), the
extended expression of Hoxb6 in PSM cells resulted in the
formation of ectopic ribs throughout the whole length of the axial
skeleton (Figures 1A and 1B), without affecting the total number
of vertebrae. In these transgenics, the prospective cervical area
contained ribs fused laterally to form an apparent articular
surface for the forelimbs, which were slightly displaced rostrally.
The prospective lumbar area also displayed ectopic ribs, pro-
gressively decreasing in size in a caudal direction, presumably
following the physiological decrease in size of the lower thoracic
ribs. In the presumptive sacral area, the vertebrae lost their
characteristic morphology and assumed rib-like features, while
keeping the lateral fusions typical of the sacral region.lopmental Cell 18, 655–661, April 20, 2010 ª2010 Elsevier Inc. 655
Figure 1. Control of Rib Formation and Myf5/Myf6 Expression by Hox Genes
(A and B) Hoxb6 overexpression in the PSM induces ectopic rib formation. Skeletal staining of wild-type (A) and Dll1-Hoxb6 (B) E18.5 fetuses. Equivalent pheno-
types were observed in 4 out of 9 transgenics.
(C–J) Hox groups 6 and 10 modulate regional expression Myf5 and Myf6. Whole-mount in situ hybridization of wild-type (C, C0, E, E0G, G0, I, and I0), Dll1-Hoxa10
(D, D0, H, and H0 ), and Dll1-Hoxb6 (F, F0, J, and J0) mouse embryos with Myf5 (C–F0) and Myf6 (G–J0 ) probes. Pictures focus on interlimb somites of Dll1-Hoxa10
embryos and their controls and forelimb somites ofDll1-Hoxb6 embryos and their controls. Arrows indicate the area of differential expression. Vibratome sections
are shown at the arrow level for each marker. Images correspond to embryos at E10.0 (28–31 somites), except for (G) and (H), which are E9.5 (24 somites).
See also Figure S1.
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Hox-Mediated Control of Rib FormationThe normal expression of Hox group 10 genes seen in Dll1-
Hoxb6 transgenics (Figures S1C–S1E) indicates that the rib
phenotype of Dll1-Hoxb6 embryos does not result from downre-
gulation of Hox group 10 genes, despite the similarities in the
phenotypes of these transgenics compared to the global group
10 deletion mutants (Wellik and Capecchi, 2003). Therefore,
Hox paralog groups 6 and 10 seem to modulate the processes
leading to rib formation in antagonistic ways. Hence, the
‘‘snake-like’’ (Dll1-Hoxb6) transgenics together with our previ-
ously described rib-less (Dll1-Hoxa10) embryos (Carapuc¸o
et al., 2005) provide a complementary system to study how
Hox genes control rib formation.
Hox Groups 6 and 10 Control Regional Hypaxial
Expression of Genes in the Myf5/Myf6 Pathway
Because ribs derive from the sclerotome (Huang et al., 2000),
we expected this somitic compartment to be affected in our
transgenics. However, we found no significant differences in
the expression patterns of sclerotomal markers such as Pax1,
Pax9, and Meox2 in the Hox transgenics (Figures S1F–S1N).
Hence, we decided to analyze the expression of genes that
have been associated with rib deficiencies in genetic studies.
Several mutations of the myogenic factor Myf5 have been
produced, and, whereas myogenesis remains relatively normal,
some mutants displayed strong rib defects that resembled
the phenotypes observed in our Dll1-Hoxa10 transgenics
(Braun et al., 1992; Tajbakhsh et al., 1996; Carapuc¸o et al.,
2005). In wild-type embryos, Myf5 expression follows specific
regional patterns. While it is expressed in the dorso-medial656 Developmental Cell 18, 655–661, April 20, 2010 ª2010 Elsevier I(epaxial) myotome of somites at all rostro-caudal levels, it
is only detected in the ventrolateral (hypaxial) myotome of
somites located between the limb buds, which are those pro-
ducing rib-bearing vertebrae (Figures 1C, 1C0, 1E, and 1E0;
Figures S1O and S1O0). In both Dll1-Hoxa10 and Dll1-Hoxb6
transgenic embryos, the distribution of Myf5 transcripts was
clearly affected. Interestingly, the changes in Myf5 expression
were region specific, correlating with the relative changes
seen in rib development. In Dll1-Hoxa10 transgenics Myf5
was downregulated specifically in the hypaxial myotome of
interlimb somites (prospective thoracic region) (Figures 1D
and 1D0), and in Dll1-Hoxb6 transgenic embryos Myf5 was
ectopically activated in the ventrolateral domain of somites at
limb and neck levels (prospective rib-less regions) (Figures 1F
and 1F0; Figures S1P and S1P0). Thus, we observe a strong
positive correlation for rib development and hypaxial Myf5
expression.
Mutations in Myf6 have also been associated with severe rib
deficiencies resembling those seen in Dll1-Hoxa10 transgenics
(Braun and Arnold, 1995), indicating that this gene could also
be a target of Hox gene activity. Expression analysis showed
patterns similar to those observed for Myf5. In Dll1-Hoxa10
transgenic embryos, Myf6 was severely downregulated, most
prominently in the hypaxial myotome of the interlimb area
(Figures 1G–1H0; see also Figures 3A0 and 3B0). Conversely,
we found ectopic Myf6 activation in the hypaxial myotomal
domain of somites at limb and neck levels in Dll1-Hoxb6 trans-
genics (Figures 1I–J0; Figures S1Q–S1R0). Interestingly, hypaxial
expression at the hindlimb level of Dll1-Hoxb6 transgenicsnc.
Figure 2. Hox Groups 6 and 10 Modulate
Regional Expression of Genes in the Myf5/
6 Pathway
Whole-mount in situ hybridization of wild-type (A,
A0, C, C0, E, G–I, and K–M), Myf5Dloxp/Dloxp (B, B0,
D, D0, and F), Dll1-Hoxa10 (H–J), and Dll1-Hoxb6
(L–N) mouse embryos with Myf6 (A–B0), Pdgfa
(C–D0, G–H0, and K–L0), and Fgf4 (E, F, I, J, M,
and N) probes. Pictures focus on interlimb somites
of Dll1-Hoxa10 embryos and their controls and
forelimb somites of Dll1-Hoxb6 embryos and their
controls. Arrows in (A)–(F) indicate the area of
conserved expression and in (G)–(N) the area of
differential expression. Vibratome sections are
shown at the arrow level for each marker. Images
correspond to embryos at E10.0 (28–31 somites)
except for (E), (F), (I), (J), (M), and (N), which are
E11.0 (40 somites). See also Figure S2.
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Hox-Mediated Control of Rib Formationpreceded that of the epaxial domain (Figures S1R and S1R0),
thus mimicking the temporal pattern that has been described
for the interlimb region in wild-type embryos (Summerbell
et al., 2002). Together, these results indicate that Hox groups 6
and 10 are able to control Myf5 and Myf6 regional specific
expression in the hypaxial myotome in a pattern that closely
correlates with rib development. Interestingly, in situ analysis
of Myf5 mutants with normal ribcages (Kaul et al., 2000; we will
refer to these mutants as Myf5Dloxp/Dloxp) revealed that while
Myf6 expression was downregulated in the epaxial myotome,
expression of Myf6 in the hypaxial myotome of interlimb somites
was clearly conserved (Figures 2A–2B0), displaying a pattern
complementary to that found in Dlll1-Hoxa10 transgenics.
Altogether, these results indicate that Hox genes are able to
control the expression of Myf5 and Myf6 in the domain that is
relevant for rib formation and are consistent with a redundant
role for these genes in rib induction.
To further evaluate Myf5/Myf6 activity in the Hox transgenics,
we tested the expression of suggested downstream effectors.
We first assayed Pdgfa and Fgf4, which were shown to be down-
regulated in Myf5 mutant embryos (Grass et al., 1996; Tallquist
et al., 2000). Expression of these genes followed patterns sim-
ilar to those described for Myf5 and Myf6. In Dll1-Hoxa10
embryos these growth factors failed to be activated in the hypax-
ial domain of interlimb somites, while the remaining expression
domains appeared largely unaffected (Figures 2G–2J). Con-
versely, Dll1-Hoxb6 embryos presented ectopic Pdgfa and
Fgf4 expression in the hypaxial domain of limb and neck somites
(Figures 2K–2N; Figures S2A–S2B0). We also observed that
Pdfga and Fgf4 expression was conserved almost exclusively
on the hypaxial myotome of interlimb somites of Myf5Dloxp/Dloxp
embryos, although the levels were lower than in control speci-
mens (Figures 2C–2F).Developmental Cell 18, 655–6Interestingly, not all Myf5 targets were
similarly affected in the Hox transgenic
embryos. Myogenin (Mgn), a Myf5 target
gene in the myogenic cascade (Pownall
et al., 2002), was upregulated in the
ventrolateral myotome of limb and neck
somites of Dll1-Hoxb6 transgenics, butits expression was not affected in Dll1-Hoxa10 embryos (Figures
S2C–S2F). While the Mgn pattern observed in Dll1-Hoxb6
embryos could result from activation by Myf5/Myf6, the fact
that Mgn is not downregulated in Dll1-Hoxa10 interlimb hypaxial
somites can be attributed to normal MyoD expression (Figures
S2G and S2H), which is also upstream of Mgn (Pownall et al.,
2002). The persistent hypaxial expression of myogenic genes
like MyoD and Mgn in Dll1-Hoxa10 transgenics is consistent
with the presence of muscles in the whole circumference of the
prospective thoracic area of these transgenics (Figure S2M). In
addition, induction of an interlimb-like Mgn expression pattern
in the hypaxial myotome at forelimb and neck levels of Dll1-
Hoxb6 transgenics is in agreement with the presence of inter-
costal muscles associated with the ribs in the neck of these
transgenics (Figures S2N and S2O). Further analysis of the
Dll1-Hoxa10 embryos with additional myotomal markers, such
as Six1 or Pax3, also revealed no significant differences when
compared to wild-type littermates (Figures S2I–S2L).
These results suggest that the effect of Hox groups 6 and 10
is quite specific for Myf5/Myf6 and not a result of a general
effect on the myotome. Furthermore, the expression of Fgf4
and Pdgfa in Dll1-Hoxa10 and Myf5Dloxp/Dloxp embryos suggests
their involvement in a Myf5/Myf6-specific pathway associated
with rib development.
Hypaxial Myf6 Expression Rescues the Rib-less
Dll1-Hoxa10 Phenotype
To determine if the Hox-modulated expression of Myf5/Myf6 is
key to rib development, we tested whether Myf6 could rescue
the rib-less Dll1-Hoxa10 phenotype when expressed in the hy-
paxial somite. As Pax3 expression seems to be unaffected by
Hoxa10 (Figures S2K and S2L), we used an enhancer of this
gene that promotes expression in the hypaxial somite (Brown61, April 20, 2010 ª2010 Elsevier Inc. 657
Figure 3. Myf5/Myf6 as Functional Targets of Hox Groups 6 and 10
Genes
(A–C) Rescue of theDll1-Hoxa10 phenotype with hypaxialMyf6. Skeletal stain-
ing of wild-type (A), Dll1-Hoxa10 (B) and Dll1-Hoxa10::Pax3Pr-Myf6 (C) E18.5
fetuses. (A0), (B0) and (C0) show Myf6 expression in the corresponding trans-
genics at E10.0.
(D) Chromatin immunoprecipitation from PSM of E9.5 wild-type mouse
embryos using antibodies against Hoxc6 (H6), Hoxa10 (H10), or an unspecific
control IgG (IgG), and PCR amplification of the Homology 1 enhancer element
(H1) and negative control region (Neg). Inp, input; Blk, blank. These results are
representative of three independent experiments.
(E) Luciferase activity from wild-type and mutated H1 enhancer (H1enh. and
H1*enh., respectively), driven by VP16:Hoxa10, VP16:Hoxb6 or the tetracy-
cline transactivator (tTA) as a control. The activation from the H1 enhancer is
statistically significant (VP16:Hoxa10 p < 0.01 and VP16:Hoxb6 p < 0.04).
The values are presented as the mean and standard error of the triplicates
from a representative experiment.
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Hox-Mediated Control of Rib Formationet al., 2005). Pax3Pr-Myf6 transgenic embryos showed no
apparent skeletal phenotype, which was expected since the hy-
paxial Pax3 enhancer reproduces the normal expression of this
gene in the hypaxial somite at the different axial levels (Brown
et al., 2005) (Figures 3A0–3C0). For the rescue experiment we
produced Pax3Pr-Myf6::Dll1-Hoxa10 double transgenics. Three
of the seven double transgenics generated had recognizable rib
phenotypes, which were much less severe than those observed
in Dll1-Hoxa10 transgenics (Figures 3A–3C). In particular, while
Dll1-Hoxa10 transgenics showed strong rib phenotypes, typi-
cally a complete absence of ribs in 65% of the cases (Figure 3B;
Table 1) (Carapuc¸o et al., 2005), Pax3Pr-Myf6::Dll1-Hoxa10658 Developmental Cell 18, 655–661, April 20, 2010 ª2010 Elsevier Idouble transgenics showed a mild alteration in the total number
of ribs combined with the presence of variable abnormal
patterns such as rib fusions, proximal gaps, and distorted rib
insertions in the sternum (Figure 3C; Table 1; Table S1).
This result indicates that Myf6 expression in the hypaxial somite
is sufficient to rescue the Hoxa10-induced rib phenotype,
thus providing further evidence of a direct contribution of this
myogenic factor to the rib phenotypes obtained in the Hox trans-
genics and its involvement in rib development.Binding of Hox Group 6 and 10 Proteins to an Enhancer
that Drives Hypaxial Expression of Myf5
Among the different control regions that have been described for
Myf5, an enhancer was identified that drives expression in the
somitic domain affected in our Hox transgenics (Bajard et al.,
2006; Buchberger et al., 2007; Giordani et al., 2007). The
homology element 1 (H1) of this enhancer (Buchberger et al.,
2007), also known as 147 bp enhancer (Bajard et al., 2006),
contains the sequence CTAATTG, which fits with predicted
target sequences for Hoxb6 and Hoxa10 (Noyes et al., 2008).
This potential Hox-binding site seems to be required for
enhancer activity according to transgenic reporter assays
(Buchberger et al., 2007). To test if our candidate Hox proteins
bind this enhancer in vivo, we performed chromatin immunopre-
cipitation experiments on PSM isolated from mouse embryos.
We could consistently immunoprecipitate the H1 enhancer ele-
ment but not other genomic areas using specific antibodies for
both Hox group 6 and 10 proteins (Figure 3D). This result
suggests a physiological positioning of these Hox proteins at
a genomic region that drives Myf5 expression in the hypaxial
myotomal domain and is consistent with a Hox-mediated regu-
lation of Myf5 in this embryonic region.
When tested using a luciferase reporter assay in cultured cells,
both Hoxa10 and Hoxb6 fused to VP16 activated transcription
from the wild-type H1 enhancer, but not from a mutant version
of this element lacking the Hox-binding site (Figure 3E), further
validating the capability of Hox proteins to bind to the CTAATTG
sequence of the H1 enhancer. The mutant version of H1 used in
these experiments still contained intact the Pax3 and Six1-
binding sites also present in this enhancer, indicating that the
CTAATTG site is the main target sequence for Hox proteins in
this regulatory element.DISCUSSION
In this study we show that specification of global vertebral
domains in the vertebrate axial skeleton is controlled by the
balanced activity of different Hox genes. It had been previously
shown that Hox groups 10 and 11 play essential roles in the
patterning of the lumbar and sacral regions, respectively (Wellik
and Capecchi, 2003; Carapuc¸o et al., 2005). Our results now
indicate that Hox genes of the paralog group 6 are able to
provide the instructions to generate the thoracic area. According
to our data, the presence of ribs is not a default state (Wellik
and Capecchi, 2003) but rather the result of a positive activity
of Hox genes that triggers processes leading to rib induction.
In caudal areas Hox group 10 proteins override this activity to
generate the rib-less areas of the skeleton. In our model, thenc.
Table 1. Comparison of the Skeletal Phenotype of Pax3pr-Myf6, Dll1-Hoxa10, and Pax3pr-Myf6::Dll1-Hoxa10 Fetuses
Pax3pr-Myf6 Dll1-Hoxa10 Pax3pr-Myf6::Dll1-Hoxa10
Wild-type FVB/N phenotypea 7/7 (100%) 2/14 (14.29%) 4/7 (57.14%)
Thoracic rib defects 0/7 (0%) 3/14 (21.43%)b 3/7 (42.86%)c
Complete rib-less phenotype 0/7 (0%) 9/14 (64.29%) 0/7 (0%)
Data are represented both as the number embryos showing a particular phenotype/total number embryos analyzed, and as percentages.
a 60% of our FVB/N-derived fetuses contain a small rib in L1.
b Variable rib defects in T1, T2, and T13.
c See Table S2 for details.
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Hox-Mediated Control of Rib Formationcervical domain is passively determined as the region anterior to
the start of the rib-determining Hox activity (Figure S3).
Surprisingly, we found that the primary target of the rib-form-
ing/rib-blocking activities of Hox genes does not seem to be the
sclerotome, but rather specific genes expressed in the myotomal
compartment. In particular, we show that the primary targets of
Hox genes are Myf5 and Myf6 specifically in the hypaxial
myotome. This implies a nonmyogenic function of Myf5/Myf6
that controls rib development. The role of Myf5 in rib formation
has been a matter of controversy. Initial studies pointed to
Myf5 as a central player in the processes leading to rib develop-
ment (Braun et al., 1992). However, when other Myf5 mutants
were produced that exhibited no rib defects (Kaul et al., 2000),
it was suggested that the rib determining factor was not Myf5
itself but another gene somehow linked to it. A decade later,
such a gene has not been identified, and recent new data once
more associated Myf5 with rib development (Gensch et al.,
2008; Haldar et al., 2008). Among the genes located close to
Myf5 in the genome, only Myf6 stands out as a candidate to be
involved in rib development, because rib phenotypes have
been described in some mutants for this gene (Braun and Arnold,
1995; Patapoutian et al., 1995; Zhang et al., 1995). Interestingly,
rib deficiencies have been observed only when inactivation of
either Myf5 or Myf6 also affected expression of the other gene
(Braun et al., 1992; Braun and Arnold, 1995; Patapoutian et al.,
1995; Tajbakhsh et al., 1996; Zhang et al., 1995; Yoon et al.,
1997; Kassar-Duchossoy et al., 2004; this work). This suggests
that Myf5 and Myf6 have redundant functions in rib formation
and that it is the double inactivation of both genes that causes
the rib phenotypes in particular Myf5 and Myf6 mutants, rather
than the effects on an additional rib-determining gene in the
Myf genomic area. Our results with both Dll1-Hoxa10 trans-
genics and Myf5Dloxp/Dloxp mutants are fully consistent with this
hypothesis. In addition, the involvement of the Myf factors in
rib development is also supported by the ability ofMyf6 to rescue
the rib-less Dll1-Hoxa10 phenotype, when expressed in the
hypaxial somite.
Our observations that Hox-driven information seems to
be first interpreted by a specific population of myotomal Myf5/-
Myf6-expressing cells could indicate that these cells can directly
contribute to the ribs. However, while cell-tracing experiments
have shown a contribution of Myf5-expressing cells to the ribs
(Gensch et al., 2008; Haldar et al., 2008), they seem to represent
too small a fraction of the rib chondrocytes to fully explain Myf5
contribution to rib development. In addition, Myf6-
expressing cells were not found in the sclerotomal compartment
using a similar cell tracing strategy (Haldar et al., 2008). There-Devefore, it seems more likely that the Myf5/Myf6-expressing cells
convey their rib-forming information to the sclerotome through
a cell nonautonomous mechanism. Our results suggest that
members of the FGF and PDGF signaling pathways are involved
in this mechanism, an idea that is also supported by genetic
studies consistent with the participation of FGFs and PDGFs in
rib formation. In particular, inactivation of Pdgf-alpha receptor
resulted in severe rib anomalies (Soriano, 1997), and insertion
of a Pdgfa cDNA in the Myf5 locus significantly rescued the
Myf5 rib phenotype (Tallquist et al., 2000). The involvement of
Fgf4 in rib formation has not been genetically addressed, but
a variety of experiments performed in chicken embryos suggest
that FGF signaling is important for rib formation (Huang et al.,
2003). Altogether, these results strongly suggest that FGF and
PDGF signaling are important components of the mechanism
that transmits patterning information from Myf5/Myf6 to the
sclerotome.
Regulation of Myf5/Myf6 by Hox genes may be a complex
process. While the activity of Hoxa10 and Hoxb6 seems to be
required before somites are formed, their effect is only detected
at a later developmental stage in a specific somitic domain.
This observation seems to be at odds with a simple transcrip-
tional activation (Hoxb6) or repression (Hoxa10) mechanism, as
it is the normal expression of Myf5 and Myf6 in the tail tip of
Dll1-Hoxb6 transgenics (Figure S1E). Therefore, Hox proteins
must functionally interact with other factors to modulate spatial
and temporally specific activity of the Myf5/Myf6 regulatory
region. Pax3 and Six1/4 are likely candidates to be involved in
this process, as they also interact functionally with the H1
enhancer through binding sites located at both sides of the
Hox site (Bajard et al., 2006; Giordani et al., 2007). Interestingly,
expression of a dominant-negative version of Pax3 from the
Pax3 locus downregulated Myf5 and Myf6 expression in the
hypaxial myotome of interlimb somites without affecting other
myogenic factors like MyoD or Mgn (Bajard et al., 2006), which
resembles our observations in Dll1-Hoxa10 transgenics. This
suggests that Hoxa10 activity could involve functional inactiva-
tion of Pax3. If this is the case, it cannot occur at the transcrip-
tional level, as Pax3 expression seemed normal in Dll1-Hoxa10
transgenics. Direct competition for binding to the enhancer is
also unlikely, because Hoxa10 activity is observed when this
gene is expressed in the PSM and not in the somites (Carapuc¸o
et al., 2005), and Pax3 is only expressed in the somites. A similar
spatial-temporal gap is observed between Pax3 expression and
Hoxb6 activity in the transgenics. This suggests a sequential
activity of Hox proteins and Pax3 (and probably Six1/4) to acti-
vate Myf5/Myf6 expression in the hypaxial myotome. A possiblelopmental Cell 18, 655–661, April 20, 2010 ª2010 Elsevier Inc. 659
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Hox-Mediated Control of Rib Formationscenario is that Hox proteins provide a label to theMyf5/6 hypax-
ial enhancer, which would promote (Hoxb6) or block (Hoxa10)
binding and/or activation by Pax3 later in the differentiating
somite, eventually regulating Myf5/Myf6 expression. Interest-
ingly, a ‘‘label-based’’ mechanism to modulate cell type-specific
recruitment of transcription factors to distal enhancers has been
recently reported (Lupien et al., 2008). Experiments are currently
in progress to test if Hox/Pax3 interactions are also mediated
through an equivalent mechanism. Of note, interactions between
Hox and Pax proteins with differential functional outcomes
have also been described for other members of the Hox and
Pax families (Yallowitz et al., 2009). Therefore, Hox-Pax func-
tional interactions could be a general theme in vertebrate
development.
It has been suggested that regulation of hypaxial Myf5 expres-
sion by Pax3 might require, in addition to the H1 enhancer, other
still not identified earlier acting elements (Bajard et al., 2006).
Similarly, it is possible that Hox-mediated modulation of Myf5/
Myf6 expression in the hypaxial myotome could involve addi-
tional components, which is consistent with the complex regula-
tion of the Myf5/Myf6 locus (Carvajal et al., 2008). A probable
location for such elements is the genomic region between 88
and 140 kb upstream of the Myf5 gene, which has been reported
to contain early hypaxial enhancers (Carvajal et al., 2001).
The Hox-mediated patterning process we describe in this
manuscript serves as a mechanism for the establishment of
global vertebral domains (i.e., cervical, thoracic, and lumbar)
through the specification of rib-containing and rib-less areas of
the skeleton. Whether Hox genes use a similar mechanism to
specify the individual features that characterize the different
vertebrae, or this is elicited by direct control of sclerotomal
development, remains to be determined. However, the primary
involvement of myotomal components in the specification of
global vertebral domains provides an evolutionarily efficient
mechanism that ensures the concomitant evolution of the
ribs and their associated muscles, to produce animals with prop-
erly organized axial musculoskeletal systems. Curiously, rib
development in turtles follows a plan that differs from that
typically observed in other amniotes, resulting in the formation
of the carapace. This specific rib development is associated
with turtle-specific Myf5 hypaxial expression in the trunk
(Ohya et al., 2006) and development of specific muscle attach-
ments (Nagashima et al., 2009), further suggesting the impor-
tance of the Myf5-rib connection in the evolution of the body
plan.
EXPERIMENTAL PROCEDURES
The Dll1-Hoxa10 construct was previously described (Carapuc¸o et al., 2005).
The Sm-Hoxb6 and Dll1-Hoxb6 constructs were generated by insertion of the
human Hoxb6 cDNA (IMAGE: 4548382) downstream of the Sm (Carapuc¸o
et al., 2005) and Dll1 (Beckers et al., 2000) enhancers, respectively, and
upstream of the SV40 polyadenylation signal. The Pax3Pr-Myf6 construct
was generated by cloning the Myf6 cDNA (IMAGE: 8733960) downstream of
the hypaxial enhancer of the Pax3 gene (Brown et al., 2005) and upstream of
the SV40 polyadenylation signal. Transgenic embryos were produced by
pronuclear injection according to standard methods. All transgenic mice
used in this work have a FVB/N genetic background. Of note, normal fetuses
derived from our FVB/N colony present a slight deviation from the typical axial
formula, as they contain a small rib in L1 with a penetrance of about 60%,
which is also observed in nonaffected transgenics with this genetic back-660 Developmental Cell 18, 655–661, April 20, 2010 ª2010 Elsevier Iground. The Myf5Dloxp/Dloxp mutants have been previously described (Kaul
et al., 2000). Fetuses were dissected at E18.5 and skeletal preparations
made using the alcian blue/alizarin red staining method (Mallo and Bra¨ndlin,
1997). Whole-mount in situ hybridization (ISH) was performed as described
elsewhere (Kanzler et al., 1998). ISH-stained embryos were embedded in
gelatin/albumin and sectioned with a vibratome.
Chromatin immunoprecipitation assays were performed using PSM from
E9.5 mouse embryos. Briefly, PSM were dissected in PBS and fixed in 1%
formaldehyde. After tissue homogenization, samples were sonicated and
immunoprecipitated using Hoxc6 antibody (Abcam ab41587), Hoxa10 anti-
body (kindly provided by J. Dasen), or control rabbit IgG (Abcam ab27478),
prebound to Dynabeads Protein A (Invitrogen). The immunoprecipitated
DNA was PCR-amplified using primers for the H1 enhancer: GCCATC
TACTCTCACACACCATAC and CCACGCTAAAATACAGACATGCAG; and
for a negative control region: CTGGCGTGTCTCCCTCTCTGCTGAA and
GCTCCGAAGGCTGCTACTCTTGGCT.
For the luciferase assays, reporter plasmids were made by cloning the
wild-type or a mutant version of the H1 enhancer in which the CAATTA was
replaced for CGCGCTG upstream of the minimal promoter of the pGL3-
Promoter Vector plasmid. Transfections were performed on 293T cells using
reporter plasmids together with plasmids expressing either VP16:Hoxa10,
VP16:Hoxb6 or, as a control, the tetracycline transactivator (tTA) (Gossen
and Bujard, 1992) using Lipofectamine 2000. The pCMV-b plasmid was
included in all electroporations for normalization. Luciferase activity was
measured on cell extracts 24 hr after transfection and normalized to b-galac-
tosidase activity. Significance was evaluated using Student’s t test.
To quantify transcript levels, total RNA was extracted with TriReagent
(Sigma) according to the manufacturer’s protocol. cDNAs were synthesized
by random priming using Superscript II reverse transcriptase (Invitrogen),
and the mRNA levels were determined by qPCR using QuantifastTM FYBR
Green PCR Kit (QIAGEN). The primers used were Hoxa10F: AGCGAGTCCTA
GACTCC and Hoxa10R: GTCCGTGAGGTGGACGCTACG; Hoxa11F: AACTT
CAAGTTCGGACAGCGG and Hoxa11R: TCAGTGAGGTTGAGCATGCGG;
Myf5F: TCCTCAGGAATGCCATCCGC and Myf5R: GACAGTAGATGCTGT
CAAAG; and Myf6F: AGACTGCCCAAGGTGGAGAT and Myf6R: AATGTTC
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